Delivery Order SPE2DB22D3501-SPE2DB25FTL67

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.64 firm fixed-price delivery order is for the supply of 4,566,790,127 dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,480.78 firm-fixed-price delivery order is for the supply of 4,566,111,129 units of the drug Dextroamphetamine-Amphetamine 25 mg capsules. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,782.07, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 30mg extended-release amphetamine medication capsules. It has an ultimate completion date of July 11, 2024. The contract is a firm fixed-price type and was awarded on a full and open competition basis without any set-aside designation....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,830.47 firm-fixed-price delivery order is for the supply of 4,565,712,396 units of dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of September 9, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.11 firm-fixed price delivery order is for the supply of 4566778943 dextroamphetamine-amphetamine 10 mg capsules, with a period of performance through December 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.96 firm-fixed-price delivery order is for the supply of 4,566,251,250 capsules of 25mg dextroamphetamine-amphetamine, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is not...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,298.32 firm fixed price delivery order is for 100 capsules of 15 mg dextroamphetamine extended-release. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,544.86 delivery order contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,048.80 Firm Fixed Price delivery order contract is for the supply of 4,567,198,853 units of Dextroamphetamine-Amphetamine 20 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTL67
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,329.62 firm fixed-price delivery order is for the supply of 4,566,407,543 units of dextroamphetamine-amphetamine extended-release 25 mg capsules. The contract has an ultimate completion date of November 13, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies. The contract award reviewed did not have a set-aside designation, indicating open competition.

Generated 2/11/25, 10:31 AM